These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

403 related articles for article (PubMed ID: 25896683)

  • 1. Camptocormia in Parkinson's disease: definition, epidemiology, pathogenesis and treatment modalities.
    Srivanitchapoom P; Hallett M
    J Neurol Neurosurg Psychiatry; 2016 Jan; 87(1):75-85. PubMed ID: 25896683
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diagnostic criteria for camptocormia in Parkinson's disease: A consensus-based proposal.
    Fasano A; Geroin C; Berardelli A; Bloem BR; Espay AJ; Hallett M; Lang AE; Tinazzi M
    Parkinsonism Relat Disord; 2018 Aug; 53():53-57. PubMed ID: 29759930
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Deep brain stimulation as a treatment for Parkinson's disease related camptocormia.
    Chieng LO; Madhavan K; Wang MY
    J Clin Neurosci; 2015 Oct; 22(10):1555-61. PubMed ID: 26321306
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immediate effect of spinal magnetic stimulation on camptocormia in Parkinson's disease.
    Arii Y; Sawada Y; Kawamura K; Miyake S; Taichi Y; Izumi Y; Kuroda Y; Inui T; Kaji R; Mitsui T
    J Neurol Neurosurg Psychiatry; 2014 Nov; 85(11):1221-6. PubMed ID: 24780955
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Camptocormia in Parkinson's disease: a review of the literature.
    Ponfick M; Gdynia HJ; Ludolph AC; Kassubek J
    Neurodegener Dis; 2011; 8(5):283-8. PubMed ID: 21389682
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of camptocormia on lung volumes in Parkinson's disease.
    Marinelli P; Colosimo C; Ferrazza AM; Di Stasio F; Fabbrini G; Palange P; Berardelli A
    Respir Physiol Neurobiol; 2013 Jun; 187(2):164-6. PubMed ID: 23570958
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The characteristics of camptocormia in patients with Parkinson's disease: A large cross-sectional multicenter study in Japan.
    Nakane S; Yoshioka M; Oda N; Tani T; Chida K; Suzuki M; Funakawa I; Inukai A; Hasegawa K; Kuroda K; Mizoguchi K; Shioya K; Sonoda Y; Matsuo H
    J Neurol Sci; 2015 Nov; 358(1-2):299-303. PubMed ID: 26428310
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Subthalamic Stimulation for Camptocormia in Parkinson's Disease: Association of Volume of Tissue Activated and Structural Connectivity with Clinical Effectiveness.
    Lai Y; Song Y; Huang P; Wang T; Wang L; Pan Y; Sun Q; Sun B; Zhang C; Li D
    J Parkinsons Dis; 2021; 11(1):199-210. PubMed ID: 33325395
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Causes of camptocormia.
    Finsterer J; Strobl W
    Disabil Rehabil; 2011; 33(17-18):1702-3. PubMed ID: 21182366
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High-frequency pallidal stimulation for camptocormia in Parkinson disease: case report.
    Thani NB; Bala A; Kimber TE; Lind CR
    Neurosurgery; 2011 May; 68(5):E1501-5. PubMed ID: 21307785
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Camptocormia and Parkinson's disease: association or consequence?].
    Frioui S; Jemni S
    Pan Afr Med J; 2015; 20():339. PubMed ID: 26175829
    [No Abstract]   [Full Text] [Related]  

  • 12. Upper camptocormia in Parkinson's disease reversed by bilateral subthalamic deep brain stimulation.
    Pandey S
    Parkinsonism Relat Disord; 2017 Apr; 37():123-124. PubMed ID: 28233683
    [No Abstract]   [Full Text] [Related]  

  • 13. [Camptocormia in patients with Parkinson's disease].
    Orekhova OA; Fedorova NV; Gamaleia AA
    Zh Nevrol Psikhiatr Im S S Korsakova; 2013; 113(7 Pt 2):13-7. PubMed ID: 23994926
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Deep brain stimulation for camptocormia in dystonia and Parkinson's disease.
    Capelle HH; Schrader C; Blahak C; Fogel W; Kinfe TM; Baezner H; Krauss JK
    J Neurol; 2011 Jan; 258(1):96-103. PubMed ID: 20803027
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term benefit of bilateral subthalamic deep brain stimulation on camptocormia in Parkinson's disease.
    Lyons M; Boucher O; Patel N; Birch B; Evidente V
    Turk Neurosurg; 2012; 22(4):489-92. PubMed ID: 22843472
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effectiveness of spinal cord stimulation for painful camptocormia with Pisa syndrome in Parkinson's disease: a case report.
    Akiyama H; Nukui S; Akamatu M; Hasegawa Y; Nishikido O; Inoue S
    BMC Neurol; 2017 Aug; 17(1):148. PubMed ID: 28774283
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A case report of thoracolumbar paraspinal myopathy as the cause of camptocormia in a patient with atypical parkinsonism.
    Kim Y; Kim A; Kim A; Jeon B
    BMC Neurol; 2017 Jun; 17(1):118. PubMed ID: 28645253
    [TBL] [Abstract][Full Text] [Related]  

  • 18. "The bent nuns convent". Antipsycotic-induced Pisa Syndrome and Camptocormia.
    Barriga-Martín A; Romero-Muñoz LM; Caba-Mora D; Rodríguez de Lope-Llorca A; López-Ariztegui N
    Neurocirugia (Astur : Engl Ed); 2021; 32(3):148-152. PubMed ID: 32651057
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of camptocormia with botulinum toxin.
    Bertram KL; Stirpe P; Colosimo C
    Toxicon; 2015 Dec; 107(Pt A):148-53. PubMed ID: 26079953
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pathophysiological Concepts and Treatment of Camptocormia.
    Margraf NG; Wrede A; Deuschl G; Schulz-Schaeffer WJ
    J Parkinsons Dis; 2016 Jun; 6(3):485-501. PubMed ID: 27314757
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.